Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Contraception and Contraceptive Drugs

Free Subscription 08.05.2023 1 Am J Obstet Gynecol 6 Contraception 5 Obstet Gynecol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
   Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
   Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
   PubMed         Abstract available
   
   

   
   Contraception

2. OSTERBUR BADHEY ML, Li S, Alimena S, Johnson NR, et al
   Allergic and infectious complications of Etonogestrel implant placements: A case series.
   Contraception. 2023;122:109994.
   PubMed         Abstract available
   
   
3. RAYMOND EG, Mark A, Grossman D, Beasley A, et al
   Medication abortion with misoprostol-only: A sample protocol.
   Contraception. 2023;121:109998.
   PubMed        
   
   
4. ANJOS FCQS, Marcelino AC, Espejo-Arce X, Pereira PDC, et al
   Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
   Contraception. 2023;122:109997.
   PubMed         Abstract available
   
   
5. WOLLUM A, Zuniga C, Blanchard K, Teal S, et al
   A commentary on progestin-only pills and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
   Contraception. 2023;122:109978.
   PubMed         Abstract available
   
   
6. CIRRINCIONE LR, Nakalema S, Chappell CA, Byakika-Kibwika P, et al
   Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
   Contraception. 2023;122:109975.
   PubMed         Abstract available
   
   
7. KOENIG LR, Raymond EG, Gold M, Boraas CM, et al
   Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
   Contraception. 2023;121:109962.
   PubMed         Abstract available
   
   

   
   Obstet Gynecol

8. QURESHEY EJ, Ibarra CJ, Wagner SM, Chen HY, et al
   Effect of a Multimedia Educational Tool on Contraception Use 1 Year Postpartum.
   Obstet Gynecol. 2023 May 4. doi: 10.1097/AOG.0000000000005198.
   PubMed         Abstract available
   
   
9. NEBLETT MF 2ND, Stewart EA
   Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
   Obstet Gynecol. 2023;141:901-910.
   PubMed         Abstract available
   
   
10. CREININ MD, Barnhart KT, Gawron LM, Eisenberg D, et al
    Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005137.
    PubMed         Abstract available
    
    
11. CHEN BA, Kimble T, Harris LH, Kerns JL, et al
    Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005147.
    PubMed         Abstract available
    
    
12. SUZUKI Y, Chen L, Hou JY, St Clair CM, et al
    Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2023 Apr 6. doi: 10.1097/AOG.0000000000005124.
    PubMed         Abstract available
    
    

    
    PLoS One

13. HARRIS ML, Egan N, Forder PM, Bateson D, et al
    Patterns of contraceptive use through later reproductive years: A cohort study of Australian women with chronic disease.
    PLoS One. 2023;18:e0268872.
    PubMed         Abstract available
    
    
14. GEBRSLASIE KZ, Berhe G, Taddese H, Weldemariam S, et al
    One-year discontinuation among users of the contraceptive pill and injection in South East Tigray region, Ethiopia.
    PLoS One. 2023;18:e0285085.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: